India Takes Another Stab At Regulating Devices As Devices
Executive Summary
As part of the Indian government's three-pronged strategy to bring the entire medtech sector under regulatory control, it has proposed new rules and finalized quality management system standards for medical devices and in vitro diagnostics.
You may also be interested in...
India Can Do More To Align New Medtech Regulations With Global Norms, Says Industry
India will finally get a device-specific regulatory framework when new rules formed by the government come into force next year. While the medtech industry has welcomed this long-awaited development, it hopes that its outstanding concerns will be addressed before the rules come into play.
Asia Reg Roundup: Updates From China, Taiwan And Korea
An end-of-year flurry of regulatory activity in the Asian medtech markets has kept industry on its toes, with initiatives in China, Taiwan and Korea, among other regions. But as Asia Regulatory Professional Association (ARPA) Secretary Jack Wong and ARQon consultant May Ng observe in this December update for Medtech Insight, governments and companies in certain markets might benefit from a little more pressure in view of the regulatory tasks they face.
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.